DrugPatentWatch Database Preview
Details for Biologics License Application: 125370
» See Plans and Pricing
Summary for BLA: 125370
Tradename: | BENLYSTA |
Applicant: | Human Genome Sciences Inc. |
Ingredient: | belimumab |
Patents: | 51 |
Approval Date: | Mar 09, 2011 |
Suppliers: see list | 1 |
Pharmacology for BLA: 125370
Drug Class | B Lymphocyte Stimulator-specific Inhibitor |
Mechanism of Action | B Lymphocyte Stimulator-directed Antibody Interactions |
Physiological Effect | Decreased B Lymphocyte Activation |
US Patents for BLA: 125370
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 001 | 2011-03-09 | Start Trial | The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) | 2039-02-26 | RX | search | |
Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 001 | 2011-03-09 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 001 | 2011-03-09 | Start Trial | Exagen Diagnostics, Inc. (Vista, CA) | 2031-02-11 | RX | search | |
Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 001 | 2011-03-09 | Start Trial | ALX ONCOLOGY INC. (Burlingame, CA) | 2035-08-07 | RX | search | |
Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 001 | 2011-03-09 | Start Trial | UBE INDUSTRIES, LTD. (Yamaguchi, JP) | 2036-04-28 | RX | search | |
Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 001 | 2011-03-09 | Start Trial | CMC BIOLOGICS A/S (Soborg, DK) | 2033-03-19 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |